Secondly, the doctor’s attitude regarding when to start insulin [10], or his/her clinical experience and competence with tackling key challenges related to insulin treatment, such as technical operation of insulin pens, hypoglycemia, weight gain and/or nonadherence, are also factors to consider [5,10,11]. The gene discussed is INS; the disease is Hypoglycemia.